Drugs / Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine
Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04006457 | Jul 2019 → Jun 2024 | alopecia areata | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04006457 ↗ |
| Modality | Vaccine | “Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine” NCT04006457 ↗ |